Laurence Turka

Laurence Turka

Corporate Officer/Principal chez Immune Tolerance Network

66 ans
Commercial Services
Health Technology
Consumer Services

Profil

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Postes actifs de Laurence Turka

SociétésPosteDébut
Corporate Officer/Principal -
Corporate Officer/Principal 01/01/1995
Corporate Officer/Principal 01/01/2003
Tous les postes actifs de Laurence Turka

Anciens postes connus de Laurence Turka

SociétésPosteFin
RUBIUS THERAPEUTICS Chief Tech/Sci/R&D Officer 31/01/2023
Founder 01/01/2020
National Institute of Allergy & Infectious Diseases Corporate Officer/Principal -
Corporate Officer/Principal -
President -
Voir l'expérience en détail de Laurence Turka

Formation de Laurence Turka

Yale School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Laurence Turka

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées8

Health Technology

National Institute of Allergy & Infectious Diseases

Government

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Laurence Turka